Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...

Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse cutaneous systemic sclerosis, according to data published in Arthritis Care ...

Scleroderma is more likely to cause serious complications if it affects your ability to breathe or process food. It can be fatal. Systemic sclerosis has three subtypes – diffuse, limited and sine ...

Reproduced with permission from [20]. Diffuse systemic sclerosis (SSc) subset, lung and cardiopulmonary involvement, thrombophilia and avascular areas on nailfold videocapillaroscopy, represent ...

A Phase 2, Multi-part, Randomized, Open-label, Assessor-blinded, Active-controlled, Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Rituximab Treatment in Participants With ...

Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.

Anifrolumab is under clinical development by AstraZeneca and currently in Phase III for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase III drugs for Systemic Sclerosis (Scleroderma) ...

Acute and chronic renal diseases remain common complications of systemic sclerosis. Although treatment ... 19 with limited and 11 with diffuse disease patterns) were treated for 5 consecutive ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis ...

2013). 4. Classified as having skin involvement proximal to the elbow and knee (diffuse cutaneous SSc subset by LeRoy and Medsger, 2001). 5. At the time of enrollment, less than or equal to 72 months ...

2 Centre de Référence des Maladies Autoimmunes Rares, Hôpitaux Universitaires de Strasbourg, Strasbourg, France Objective To describe systemic sclerosis (SSc) with myopathy in patients without classic ...

Systemic and cutaneous mastocytosis encompass the 2 major categories of mastocytosis. A 19-month-old female child presented with acute hypoxemic respiratory failure, which was thought to be secondary ...